Logo

Tm Extends Alliance With Luminex to Sell Dx Products On xMAP Platform

Mar 29, 2006

NEW YORK, March 29 (GenomeWeb News) - Tm Bioscience has extended for  multiple additional years an agreement with Luminex to sell DNA-based molecular diagnostics that operate on Luminex's xMAP platform, Tm said today.

 

All of Tm's genetic tests use its Tag-It Universal Array platform. Tm's assays, meantime, use Luminex's xMAP platform.

 

The original agreement between the two companies, launched in 2001, expired yesterday. The renegotiated deal incorporates "similar terms" to the original, including the ability for Tm to distribute such xMAP systems as the new LX200 instrument, Tm said.


Financial terms of the deal were not disclosed.

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.